Wide-reaching report finds strong support for nurse and pharmacist prescribing

Greater powers introduced by the government to enable specially trained nurses and pharmacists to prescribe medication in England have been successfully adopted, according to a new report

 

Southampton (May 10, 2011) – Greater powers introduced by the government to enable specially trained nurses and pharmacists to prescribe medication in England have been successfully adopted, according to a new report.

 

Health service researchers from the universities of Southampton and Keele found widespread acceptance of the new powers among patients and that prescribing practices were safe and appropriate for the type of medical conditions being treated.

 

The Department of Health-funded report, published today (Tuesday, 10 May 2011), gives a national ‘snapshot’ of how successfully nurse and pharmacist prescribing is being used in primary care trusts, GP surgeries and hospitals.

 

"This study is the first national evaluation of independent prescribing by nurses and pharmacists since legislation in 2006 enabled nurses and pharmacists to independently prescribe across an extensive range of medicines. Our research shows that the practice is becoming a well–integrated and established means of managing a patient’s condition," comments Sue Latter, professor of nursing at the University of Southampton, who led the study.

 

"We were also able to highlight areas to the government where expansion of non-medical prescribing could strengthen NHS services in order to meet health care needs of the future."

 

The legislation, which gave experienced nurses and pharmacists powers to prescribe medication to patients, was viewed by some as controversial when it was introduced in 2006. Specially trained nurses and pharmacists in England are now able to manage all aspects of a patient’s treatment including diagnosis, prescription and monitoring, without supervision by a doctor.

 

"Our research shows that nurse and pharmacist independent prescribers are now making a substantial contribution to patient care which is safe and of good quality," says Alison Blenkinsopp, professor of the practice of pharmacy at Keele University.

 

"Commissioners of healthcare can use our findings to make the most effective use of nurse and pharmacist prescribing when they are commissioning services."

 

The report also found that:

 

  • 86 per cent of nurses and 71 per cent of pharmacists are using their new powers after training as a prescriber.
  • Most nurses and pharmacists are prescribing in a primary care setting, with substantial numbers also in secondary care settings, such as hospitals.
  • Most patients did not mind whether they received care from a nurse, pharmacist or a doctor.
  • Enabling non-medical prescribing to develop further, by additional training of nurses and pharmacists to treat patients with more than one medical condition, could improve patient care and efficiency in the health service.

 


 

University of Southampton, Sophie Docker; Nursing News 10.05.2011 (tB).

MEDICAL NEWS

Inadequate sequencing of SARS-CoV-2 variants impedes global response to COVID-19
New meta-analysis finds cannabis may be linked to development of…
New guidance on how to diagnosis and manage osteoporosis in…
Starting the day off with chocolate could have unexpected benefits
Better mental health supports for nurses needed, study finds

SCHMERZ PAINCARE

Versorgung verbessern: Deutsche Gesellschaft für Schmerzmedizin fordert die Einführung des…
Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…
Jedes vierte Kind wünscht bessere Schmerzbehandlung
Lebensqualität von Patienten in der dauerhaften Schmerztherapie mit Opioiden verbessern

DIABETES

Bundestag berät über DMP Adipositas: DDG begrüßt dies als Teil…
Mit der Smartwatch Insulinbildung steuern
Verbände fordern bessere Ausbildung und Honorierung von Pflegekräften für Menschen…
Minimalinvasive Geräte warnen ungenügend vor Unterzuckerung
Typ-1-Diabetes und Hashimoto-Thyreoiditis treten häufig gemeinsam auf

ERNÄHRUNG

Wie eine Diät die Darmflora beeinflusst: Krankenhauskeim spielt wichtige Rolle…
DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?
Regelmässiger Koffeinkonsum verändert Hirnstrukturen
Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren

ONKOLOGIE

Anti-Myelom-Therapie mit zusätzlich Daratumumab noch effektiver
Positive Ergebnisse beim fortgeschrittenen Prostatakarzinom: Phase-III-Studie zur Radioligandentherapie mit 177Lu-PSMA-617
Lymphom-News vom EHA2021 Virtual. Alle Berichte sind nun online verfügbar!
Deutsch-dänisches Interreg-Projekt: Grenzübergreifende Fortbildungskurse in der onkologischen Pflege
Sotorasib: Neues Medikament macht Lungenkrebs-Patienten Hoffnung

MULTIPLE SKLEROSE

NMOSD-Erkrankungen: Zulassung von Satralizumab zur Behandlung von Jugendlichen und Erwachsenen
Verzögerte Verfügbarkeit von Ofatumumab (Kesimpta®)
Neuer Biomarker bei Multipler Sklerose ermöglicht frühe Risikoeinschätzung und gezielte…
Multiple Sklerose beginnt oft lange vor der Diagnose
Goldstandard für Versorgung bei Multipler Sklerose

PARKINSON

Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…
Gemeinsam gegen Parkinson: bessere Therapie durch multidisziplinäre Versorgung